Suppr超能文献

同步性霍奇金淋巴瘤与胃腺癌:一例罕见病例报告及文献综述

Synchronous Hodgkin lymphoma and gastric adenocarcinoma: A rare case report and literature review.

作者信息

Wu Hongying, Wei Liyan, Hao Lumei, Li Xuemei, Wang Lei, Yuan Chenglu

机构信息

Qingdao Municipal Hospital (group) Shandong University Qilu Hospital (Qingdao), Qingdao, Shandong, China.

出版信息

Medicine (Baltimore). 2018 Jan;97(3):e9484. doi: 10.1097/MD.0000000000009484.

Abstract

Hodgkin lymphoma (HL) is a lymphoproliferative disease arising in the lymphoid tissue, which is characterized by Reed-Sternberg cells. Adenocarcinoma is the most frequent pathological type of stomach cancer. Improved survival in HL patients leads to the development of secondary malignancies. However, synchronous occurrence of these 2 malignancies is extremely rare. Here, we present a 45-year-old male complaining of a lymph node mass in the neck, without any abdominal symptoms, diagnosed as HL and gastric adenocarcinoma with hepatitis B carrier status. We treated the patient with 8 courses of pirarubicin bleomycin, vincristine, and dacarbazine (modified ABVD), and 4 courses of capecitabine therapy concurrently along with oral entecavir, as the patient survived longer than 20 months.The prognosis of multiple primary malignancies is poor because therapy is difficult, without a standard treatment. The frequency of multiple primary malignancies is increasing in recent years, and second malignancies in patients with cancer should be taken into consideration.

摘要

霍奇金淋巴瘤(HL)是一种起源于淋巴组织的淋巴增殖性疾病,其特征为里德-斯腾伯格细胞。腺癌是胃癌最常见的病理类型。HL患者生存率的提高导致了继发性恶性肿瘤的发生。然而,这两种恶性肿瘤同时出现极为罕见。在此,我们报告一名45岁男性,主诉颈部淋巴结肿块,无任何腹部症状,被诊断为HL和胃腺癌,同时为乙肝携带者。由于患者存活超过20个月,我们用8个疗程的吡柔比星、博来霉素、长春新碱和达卡巴嗪(改良ABVD)以及4个疗程的卡培他滨治疗该患者,同时口服恩替卡韦。多种原发性恶性肿瘤的预后较差,因为治疗困难且没有标准治疗方案。近年来,多种原发性恶性肿瘤的发生率在增加,癌症患者的继发性恶性肿瘤应予以考虑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9756/5779740/32b3033071be/medi-97-e9484-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验